Placebo
OtherBeverage with no flavonoids
NCT Number: NCT03585868
The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo to evaluate the effect of daily consumption of a cocoa beverage on anthropometric, metabolic, oxidative stress, physical performance and quality of life.
Looking for future studies?
Notify Me55 year–90 year
All sexes
Interventional
Not applicable
The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo randomly assigned to consumption of a flavonoid rich mixture (flavonoids; F), alkalinized cocoa which eliminates flavonoid content (no flavonoids; NF) or placebo. All beverages had similar physical characteristics and flavor. Cocoa beverages were provided in individual sachets containing a dry powder that was reconstituted with water just before consumption. Subjects were instructed as above to maintain their usual lifestyle, to limit intake of high caloric foods and flavonoid-containing foods and beverages, and to walk for 30 min/day.
To determine the effect of flavonoids, study evaluates anthropometric measures, metabolic parameters as glycemia and a lipid profile (triglycerides, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol). To evaluate oxidative stress damage as lipid oxidation is measured with the malondialdehyde (MDA) assay. Protein carbonylation is measured using an assay for detection of carbonyl groups that relies on 2,4-dinitrophenylhydrazine (DNPH) as a substrate. The investigators also evaluate interleukin-6 and tumor necrosis factor levels.
For physical performance is evaluated the handgrip strength, and mobility assesment with the following test: Six-minute walk test, two-minute step, sit-up test and the up & go test.
The investigators also assessed quality of life using the Health Related QoL (EQ-5D) questionnaire.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non-inclusion criteria:
Beverage with no flavonoids
Flavonoids-enriched cacao beverage
Beverage with alkalinized cocoa which eliminates flavonoid content
Time frame: At 90 days
Fasting blood level
Time frame: At 90 days
Fasting blood level
Time frame: At 90 days
Fasting blood level
Time frame: At 90 days
Fasting blood level
Time frame: At 90 days
Fasting blood level
Time frame: At 90 days
Serum malondialdehyde Levels
Time frame: At 90days
Serum protein carbonylation Levels
Time frame: At 60 days
Measures static force in kilograms that the hand can squeeze around a dynamometer
Time frame: At 60 days
Measures time in seconds, a subject can rise and walk a 3-meter line and return to sit down
Time frame: 6 minutes
Measures maximum distance in meters, a subject can walk at their normal gait and pace during 6 minutes
Time frame: 2 minutes
Measures number of times a subject can rise each knee to the hip level during 2 minutes.
Time frame: 30 seconds
Measures number of times a subject can rise and sit-down in place during 30 seconds
Time frame: At 60 days
Self-administered health index that explores five domains
Time frame: At 60 days
Use of a Analog Visual Scale to measure the quality of life, graded 0 (worst) to 100 (best) for the perception of wellbeing.
National Polytechnic Institute, Mexico
Other
Evaluation of the Effects of a COcoa Supplement to Reduce FRailty in the Elderly: COFRE a Randomized Clinical Trial
Acronym: COFRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05393362
Atrophy, Cardiovascular Diseases
Málaga, Spain
View Trial DetailsNCT03636412
Atrophy, Frail Elderly Syndrome
Cleveland, Ohio, United States
View Trial DetailsNCT03413449
Atrophy, Digestive System Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT04574271
Atrophy, Frail Elderly Syndrome
Medina del Campo, Valladolid, Spain
View Trial Details